Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017
According to their website, NewsMakers presents a hand-picked
group of public biotech companies whose corporate and regulatory
milestones are expected to drive stock prices, and describes itself as
the best opportunity for business development executives and key members
of the institutional investment and analyst communities to compare notes
and assess the industry landscape. The 2016 conference represented more
than 500 delegates, including money managers with more than
Mr. Egan commented: “NewsMakers is recognized as a key venue in
the industry for companies to present their story to the investment
This press release contains forward-looking statements. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Andrew Benson, Investor Relations